Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-01-03 Sale | 2022-01-05 8:48 pm | G1 Therapeutics Inc. | GTHX | Hanson James S. General Counsel | 1,445 | $10.61 | $15,334 | 78,555 (Direct) | View |
| 2022-01-03 Sale | 2022-01-05 8:25 pm | G1 Therapeutics Inc. | GTHX | MURDOCK TERRY L Chief Operating Officer | 1,445 | $10.61 | $15,334 | 74,555 (Direct) | View |
| 2022-01-03 Sale | 2022-01-05 8:25 pm | G1 Therapeutics Inc. | GTHX | Moses Jennifer K. CFO | 1,445 | $10.61 | $15,334 | 88,555 (Direct) | View |
| 2022-01-03 Sale | 2022-01-05 8:24 pm | G1 Therapeutics Inc. | GTHX | Malik Rajesh Chief Medical Officer | 1,445 | $10.61 | $15,334 | 116,855 (Direct) | View |
| 2022-01-03 Sale | 2022-01-05 8:24 pm | G1 Therapeutics Inc. | GTHX | Avagliano Mark Chief Business Officer | 1,445 | $10.61 | $15,334 | 74,555 (Direct) | View |
| 2022-01-03 Sale | 2022-01-05 8:24 pm | G1 Therapeutics Inc. | GTHX | Bailey John E. (Jack) Jr. CEO | 34,125 | $10.41 | $355,262 | 437,208 (Direct) | View |
| 2021-07-13 Sale | 2021-07-15 4:01 pm | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 30,000 | $19.01 | $570,258 | 772,858 (Direct) | View |
| 2021-06-29 Sale | 2021-06-30 4:05 pm | G1 Therapeutics Inc. | GTHX | RUDNICK SETH Director | 10,000 | $22.35 | $223,477 | 21,514 (Indirect Direct) | View |
| 2021-06-15 Sale | 2021-06-17 4:05 pm | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 30,000 | $21.97 | $659,021 | 862,858 (Direct) | View |
| 2021-05-11 Sale | 2021-05-13 4:43 pm | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 30,000 | $19.9 | $597,101 | 992,858 (Direct) | View |
| 2021-04-22 Sale | 2021-04-23 4:39 pm | G1 Therapeutics Inc. | GTHX | Malik Rajesh Chief Medical Officer | 15,000 | $22.07 | $331,100 | 82,739 (Direct) | View |
| 2021-04-13 Sale | 2021-04-15 5:53 pm | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 30,000 | $24.46 | $733,768 | 1,082,858 (Direct) | View |
| 2021-03-23 Sale | 2021-03-24 4:47 pm | G1 Therapeutics Inc. | GTHX | Malik Rajesh Chief Medical Officer | 15,000 | $21.94 | $329,060 | 97,739 (Direct) | View |
| 2021-03-02 Sale | 2021-03-04 5:10 pm | G1 Therapeutics Inc. | GTHX | Malik Rajesh Chief Medical Officer | 15,000 | $22.95 | $344,192 | 149,663 (Direct) | View |
| 2021-02-16 Sale | 2021-02-18 5:49 pm | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 31,040 | $29.81 | $925,238 | 156,179 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-06-27 Option Award | 2022-06-29 5:56 pm | N/A 2032-06-27 | G1 Therapeutics Inc. | GTHX | Lee Jacks Director | 60,000 | $0 | 60,000 (Direct) | View |
| 2022-06-23 Option Award | 2022-06-24 4:51 pm | N/A 2032-06-23 | G1 Therapeutics Inc. | GTHX | Secor Alicia Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2022-06-23 Option Award | 2022-06-24 4:51 pm | N/A 2032-06-23 | G1 Therapeutics Inc. | GTHX | Nicholson Garry A Director | 40,000 | $0 | 44,389 (Direct) | View |
| 2022-06-23 Option Award | 2022-06-24 4:51 pm | N/A 2032-06-23 | G1 Therapeutics Inc. | GTHX | Deese Willie A Director | 40,000 | $0 | 44,389 (Direct) | View |
| 2022-06-23 Option Award | 2022-06-24 4:51 pm | N/A 2032-06-23 | G1 Therapeutics Inc. | GTHX | Flowers Cynthia Louise Director | 40,000 | $0 | 45,889 (Direct) | View |
| 2022-06-23 Option Award | 2022-06-24 4:51 pm | N/A 2032-06-23 | G1 Therapeutics Inc. | GTHX | MUIR GLENN P Director | 40,000 | $0 | 215,358 (Direct) | View |
| 2022-02-07 Exercise | 2022-02-08 4:05 pm | N/A 2024-05-09 | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 15,000 | $0 | 288,286 (Direct) | View |
| 2022-02-07 Exercise | 2022-02-08 4:05 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 15,000 | $0.39 | 288,286 (Direct) | View |
| 2022-02-01 Exercise | 2022-02-02 5:20 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Moses Jennifer K. CFO | 2,000 | $4.17 | 95,888 (Direct) | View |
| 2022-02-01 Exercise | 2022-02-02 5:20 pm | N/A 2026-05-10 | G1 Therapeutics Inc. | GTHX | Moses Jennifer K. CFO | 2,333 | $0 | 95,888 (Direct) | View |
| 2022-02-01 Exercise | 2022-02-02 5:20 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Moses Jennifer K. CFO | 333 | $3.72 | 95,888 (Direct) | View |
| 2022-02-01 Exercise | 2022-02-02 5:20 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Malik Rajesh Chief Medical Officer | 10,000 | $0.3 | 128,855 (Direct) | View |
| 2022-02-01 Exercise | 2022-02-02 5:20 pm | N/A 2025-02-27 | G1 Therapeutics Inc. | GTHX | Malik Rajesh Chief Medical Officer | 10,000 | $0 | 128,855 (Direct) | View |
| 2022-01-03 Option Award | 2022-01-05 8:48 pm | N/A 2032-01-03 | G1 Therapeutics Inc. | GTHX | Hanson James S. General Counsel | 65,000 | $0 | 78,555 (Direct) | View |
| 2022-01-03 Option Award | 2022-01-05 8:25 pm | N/A 2032-01-03 | G1 Therapeutics Inc. | GTHX | Perry Andrew Chief Commercial Officer | 32,500 | $0 | 32,520 (Direct) | View |
| 2022-01-03 Option Award | 2022-01-05 8:25 pm | N/A 2032-01-03 | G1 Therapeutics Inc. | GTHX | MURDOCK TERRY L Chief Operating Officer | 65,000 | $0 | 74,555 (Direct) | View |
| 2022-01-03 Option Award | 2022-01-05 8:25 pm | N/A 2032-01-03 | G1 Therapeutics Inc. | GTHX | Moses Jennifer K. CFO | 65,000 | $0 | 88,555 (Direct) | View |
| 2022-01-03 Option Award | 2022-01-05 8:24 pm | N/A 2032-01-03 | G1 Therapeutics Inc. | GTHX | Malik Rajesh Chief Medical Officer | 65,000 | $0 | 116,855 (Direct) | View |
| 2022-01-03 Option Award | 2022-01-05 8:24 pm | N/A 2032-01-03 | G1 Therapeutics Inc. | GTHX | Avagliano Mark Chief Business Officer | 65,000 | $0 | 74,555 (Direct) | View |
| 2022-01-03 Option Award | 2022-01-05 8:24 pm | N/A 2032-01-03 | G1 Therapeutics Inc. | GTHX | Bailey John E. (Jack) Jr. CEO | 250,000 | $0 | 437,208 (Direct) | View |
| 2021-11-09 Exercise | 2021-11-10 4:05 pm | N/A 2024-05-09 | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 40,000 | $0 | 288,286 (Direct) | View |
| 2021-11-09 Exercise | 2021-11-10 4:05 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 40,000 | $0.39 | 288,286 (Direct) | View |
| 2021-08-16 Option Award | 2021-08-17 4:53 pm | N/A 2031-08-16 | G1 Therapeutics Inc. | GTHX | Perry Andrew Chief Commercial Officer | 300,000 | $0 | 300,000 (Direct) | View |
| 2021-08-16 Ownership | 2021-08-17 4:53 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Perry Andrew Chief Commercial Officer | 0 | $0 | 20 (Direct) | View |
| 2021-07-13 Exercise | 2021-07-15 4:01 pm | N/A 2024-05-09 | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 30,000 | $0 | 772,858 (Direct) | View |
| 2021-07-13 Exercise | 2021-07-15 4:01 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 30,000 | $0.39 | 772,858 (Direct) | View |
| 2021-06-29 Exercise | 2021-06-30 4:05 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | RUDNICK SETH Director | 2,031 | $0.3 | 21,514 (Direct) | View |
| 2021-06-29 Exercise | 2021-06-30 4:05 pm | N/A 2025-02-27 | G1 Therapeutics Inc. | GTHX | RUDNICK SETH Director | 10,000 | $0 | 21,514 (Direct) | View |
| 2021-06-29 Exercise | 2021-06-30 4:05 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | RUDNICK SETH Director | 7,969 | $0.39 | 21,514 (Direct) | View |
| 2021-06-17 Option Award | 2021-06-21 4:45 pm | N/A 2031-06-17 | G1 Therapeutics Inc. | GTHX | Secor Alicia Director | 52,320 | $0 | 52,320 (Direct) | View |
| 2021-06-17 Option Award | 2021-06-21 4:25 pm | N/A 2031-06-17 | G1 Therapeutics Inc. | GTHX | Schwalm Cynthia Director | 24,009 | $0 | 25,509 (Direct) | View |
| 2021-06-17 Option Award | 2021-06-21 4:06 pm | N/A 2031-06-17 | G1 Therapeutics Inc. | GTHX | RUDNICK SETH Director | 24,009 | $0 | 29,275 (Direct) | View |
| 2021-06-17 Option Award | 2021-06-21 4:06 pm | N/A 2031-06-17 | G1 Therapeutics Inc. | GTHX | Nicholson Garry A Director | 24,009 | $0 | 24,009 (Direct) | View |
| 2021-06-17 Option Award | 2021-06-21 4:05 pm | N/A 2031-06-17 | G1 Therapeutics Inc. | GTHX | MUIR GLENN P Director | 24,009 | $0 | 194,978 (Direct) | View |
| 2021-06-17 Option Award | 2021-06-21 4:05 pm | N/A 2031-06-17 | G1 Therapeutics Inc. | GTHX | Deese Willie A Director | 24,009 | $0 | 24,009 (Direct) | View |
| 2021-06-15 Exercise | 2021-06-17 4:05 pm | N/A 2024-05-09 | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 30,000 | $0 | 862,858 (Direct) | View |
| 2021-06-15 Exercise | 2021-06-17 4:05 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 30,000 | $0.39 | 862,858 (Direct) | View |
| 2021-05-25 Exercise | 2021-05-25 6:29 pm | N/A 2024-05-09 | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 20,000 | $0 | 348,286 (Direct) | View |
| 2021-05-25 Exercise | 2021-05-25 6:29 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 20,000 | $0.39 | 348,286 (Direct) | View |
| 2021-05-11 Exercise | 2021-05-13 4:43 pm | N/A 2024-05-09 | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 30,000 | $0 | 992,858 (Direct) | View |
| 2021-05-11 Exercise | 2021-05-13 4:43 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 30,000 | $0.39 | 992,858 (Direct) | View |
| 2021-05-10 Exercise | 2021-05-11 4:23 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Malik Rajesh Chief Medical Officer | 10,000 | $0.3 | 118,300 (Direct) | View |
| 2021-05-10 Exercise | 2021-05-11 4:23 pm | N/A 2025-02-27 | G1 Therapeutics Inc. | GTHX | Malik Rajesh Chief Medical Officer | 10,000 | $0 | 118,300 (Direct) | View |
| 2021-04-22 Exercise | 2021-04-23 4:39 pm | N/A 2024-07-11 | G1 Therapeutics Inc. | GTHX | Malik Rajesh Chief Medical Officer | 15,000 | $0 | 82,739 (Direct) | View |
| 2021-04-22 Exercise | 2021-04-23 4:39 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Malik Rajesh Chief Medical Officer | 15,000 | $0.39 | 82,739 (Direct) | View |
| 2021-04-13 Exercise | 2021-04-15 5:53 pm | N/A 2024-05-09 | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 30,000 | $0 | 1,082,858 (Direct) | View |
| 2021-04-13 Exercise | 2021-04-15 5:53 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 30,000 | $0.39 | 1,082,858 (Direct) | View |
| 2021-03-23 Exercise | 2021-03-24 4:47 pm | N/A 2024-07-11 | G1 Therapeutics Inc. | GTHX | Malik Rajesh Chief Medical Officer | 15,000 | $0 | 97,739 (Direct) | View |
| 2021-03-23 Exercise | 2021-03-24 4:47 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Malik Rajesh Chief Medical Officer | 15,000 | $0.39 | 97,739 (Direct) | View |
| 2021-03-02 Exercise | 2021-03-04 5:10 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Malik Rajesh Chief Medical Officer | 4,595 | $4.17 | 149,663 (Direct) | View |
| 2021-03-02 Exercise | 2021-03-04 5:10 pm | N/A 2026-05-10 | G1 Therapeutics Inc. | GTHX | Malik Rajesh Chief Medical Officer | 15,000 | $0 | 149,663 (Direct) | View |
| 2021-03-02 Exercise | 2021-03-04 5:10 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Malik Rajesh Chief Medical Officer | 10,405 | $0.39 | 149,663 (Direct) | View |
| 2021-03-03 Exercise | 2021-03-04 4:54 pm | N/A 2025-12-21 | G1 Therapeutics Inc. | GTHX | Moses Jennifer K. CFO | 3,000 | $0 | 25,333 (Direct) | View |
| 2021-03-03 Exercise | 2021-03-04 4:54 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Moses Jennifer K. CFO | 3,000 | $3.72 | 25,333 (Direct) | View |
| 2021-02-16 Exercise | 2021-02-18 5:49 pm | N/A 2025-12-21 | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 31,040 | $0 | 156,179 (Direct) | View |
| 2021-02-16 Exercise | 2021-02-18 5:49 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 31,040 | $3.72 | 156,179 (Direct) | View |
| 2021-01-27 Exercise | 2021-01-29 4:07 pm | N/A 2024-07-11 | G1 Therapeutics Inc. | GTHX | Malik Rajesh Chief Medical Officer | 3,100 | $0 | 123,144 (Direct) | View |
| 2021-01-27 Exercise | 2021-01-29 4:07 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Malik Rajesh Chief Medical Officer | 3,100 | $0.39 | 123,144 (Direct) | View |